Please visit Nilogen's poster #206 at the virtual EORTC-NCI-AACR #EORTC conference to learn more about evaluating your cell therapy using our fresh patient 3D ex vivo platform and check out our website to learn more! @nilogenonc https://t.co/mSuxLHRz0d
⏰ LAST DAY TO ENTER ⏰
Sign up for Nature Briefing for a chance to win a library of six of the best science books of the season 📚
Enter at https://t.co/kS0XsqsqTG
Nilogen Oncosystems is a 2020 @GrowFL Florida Companies to Watch Finalist! The Honorees will be announced during a live program on November 12. Want to tune in with us? Register here: https://t.co/sppXPfWpro #FLCTW
Please visit Nilogen's 3D-EX poster today at the virtual #AACR2020 conference and stop by our website to download the posters and learn more! @nilogenonc https://t.co/EnQaRvmyu8
Please visit Nilogen's 3D-Screen poster today at the virtual #AACR2020 conference and stop by our website to download the posters and learn more! @nilogenonc https://t.co/M0yTpX9GEi
How does immunotherapy work? Our short video explains how three types of #immunotherapy work against cancer: https://t.co/YfaQEzOEMU #checkpointinhibitor
In 2019 there were an estimated 228,150 new cases of #LungCancer in the United States. To learn more, visit our stat fact sheet: https://t.co/BVqvN4e1pm
"The device has allowed Chou's team to investigate how microgravity affects different diseases. The scientists report it has been tremendously effective so far in eliminating cancer cells."
#immunooncology#exvivotumororganoids#patienttumorexplantmodel
https://t.co/Bn3khhn7as
Drop by the Building Entrepreneurship Around Tampa Bay (BEAT) event at USF Connect today to learn more about Nilogen's Immuno-oncology drug development services.
#USFBEAT2019#GEW2019
Nilogen will present a poster entitled "Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples " today at 12:30pm at the SITC Annual Meeting. The poster number is P740.
#SITC2019
Drop by Booth #624 at the SITC Annual Meeting today to learn more about Nilogen's novel immuno-oncology drug development services and the benefits of our ex vivo fresh patient tumor organoids.
#SITC2019#Immunotherapy#immunoOncology
See Nilogen Senior Scientist Mibel Pabón present her poster "A Patient-driven Ex Vivo 3D Tumor Organoid Model to Assess Efficacy of Tumor Infiltrating T-cell Adoptive Cell Therapy" today at 12:30pm at the SITC annual meeting. The poster number is 207.
#SITC2019